从评估到行动:临床实验室整合指标评价与不良事件分析的质量改进实践
本研究依据ISO 15189:2022,评估某医院实验室2023年15项质量指标并与国家及国际基准比较,识别差距后于2024年实施数据驱动的持续改进项目并监测不良事件。排除室内质控和室间比对指标后,其余13项指标σ>3.5,7项指标显著改善(p<0.05),实验室绩效国内排名较低但国际排名较好,15起不良事件涉及全流程多部门。
要点
- 13项质量指标σ>3.5,7项在2024年显著改善(p<0.05)。
- 实验室绩效国内排名较低,国际排名较好。
- 15起不良事件覆盖检验全流程并涉及多部门。
核心结论
- 2024年实施的质量改进措施带来了可测量的改善。
- 有效沟通和跨学科协作对减少错误和提升实验室绩效至关重要。
研究设计与样本
- 评估2023年15项质量指标,比较百分比和σ水平与国家基准以识别差距。
- 基于分析于2024年实施数据驱动的持续改进项目,并密切监测不良事件采取纠正措施。
- 比较2023至2024年数据与国家及国际规范,使用R Studio进行统计分析。
主要发现
- 排除室内质控和室间比对指标后,其余13项质量指标σ>3.5。
- 7项指标出现统计学显著改善(p<0.05)。
- 实验室绩效国内排名相对较低,国际排名较好。
- 15起不良事件分析显示错误发生在所有检验阶段并涉及多个部门。
临床怎么用
- 依据ISO 15189:2022使用质量指标监测实验室绩效并推动持续改进。
- 将质量指标与国家和国际质量规范比较以识别性能差距。
- 监测不良事件并采取纠正措施,加强沟通和跨学科协作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: ISO 15189:2022 recommends the use of quality indicators (QIs) to monitor laboratory performance and focuses on risk management and continual improvement. This study aims to compare hospital laboratory data with national and international quality specifications and to share experiences in quality improvement and adverse event management. METHODS: We evaluated 15 QIs from 2023 by comparing their percentages and sigma levels with those of national benchmarks to identify performance gaps. On the basis of this analysis, a series of data-driven continuous improvement projects were implemented in 2024. Adverse events were closely monitored and corrective actions were taken accordingly. Data from 2023 to 2024 were compared with national and international specifications, and statistical analysis was conducted using R Studio. RESULTS: Excluding internal quality control and interlaboratory comparison indicators, the remaining 13 QIs generally exhibited acceptable performance (σ>3.5). Statistically significant improvements (p<0.05) were observed in seven indicators. Overall, laboratory performance was ranked relatively low at the national level but favourably at the international level. The analysis of 15 adverse events revealed that errors occurred across all testing phases and involved multiple departments. CONCLUSIONS: The quality improvement initiatives implemented in 2024 yielded measurable improvements. Effective communication and interdisciplinary collaboration are essential for reducing errors and enhancing laboratory performance.
引用
- Chen P, Chen X, Xia Y, et al. From assessment to action: experience from a quality improvement initiative integrating indicator evaluation and adverse event analysis in a clinical laboratory. Clin Chem Lab Med. 2025. PMID: 40831396. doi:10.1515/cclm-2025-0656
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。